ARKG vs. GERM
ARKG (ARK Genomic Revolution Multi-Sector ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds. ARKG is actively managed, while GERM is passively managed. Over the past year, ARKG returned 59.88% vs 0.00% for GERM. ARKG charges 0.75%/yr vs 0.68%/yr for GERM.
Performance
ARKG vs. GERM - Performance Comparison
Loading charts...
Returns By Period
ARKG
- 1D
- 7.14%
- 1M
- 25.79%
- YTD
- 33.17%
- 6M
- 27.83%
- 1Y
- 59.88%
- 3Y*
- 5.57%
- 5Y*
- -15.49%
- 10Y*
- 9.42%
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ARKG vs. GERM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 33.17% | 23.04% | -5.71% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
ARKG vs. GERM - Sectors Allocation Comparison
Sectors
ARKG
GERM
Healthcare
Financial Services
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
ARKG
GERM
Financial Services
ARKG
GERM
Basic Materials
ARKG
-
GERM
-
Communication Services
ARKG
-
GERM
-
Consumer Cyclical
ARKG
-
GERM
-
Consumer Defensive
ARKG
-
GERM
-
Energy
ARKG
-
GERM
-
Industrials
ARKG
-
GERM
-
Real Estate
ARKG
-
GERM
-
Technology
ARKG
-
GERM
-
Utilities
ARKG
-
GERM
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKG vs. GERM — Risk / Return Rank
ARKG
GERM
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
ARKG vs. GERM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARKG | GERM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.24 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 2.19 | — | — |
| Martin ratioReturn relative to average drawdown | 5.21 | — | — |
Loading charts...
Drawdowns
ARKG vs. GERM - Drawdown Comparison
The maximum ARKG drawdown since its inception was -83.59%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for ARKG and GERM.
Loading charts...
Drawdown Indicators
| ARKG | GERM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.59% | 0.00% | -83.59% |
Max Drawdown (1Y)Largest decline over 1 year | -27.51% | 0.00% | -27.51% |
Max Drawdown (3Y)Largest decline over 3 years | -51.96% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -80.18% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -83.59% | — | — |
Current DrawdownCurrent decline from peak | -65.48% | 0.00% | -65.48% |
Average DrawdownAverage peak-to-trough decline | -36.03% | 0.00% | -36.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.53% | 0.00% | +11.53% |
Volatility
ARKG vs. GERM - Volatility Comparison
ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 16.36% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKG | GERM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.36% | 0.00% | +16.36% |
Volatility (6M)Calculated over the trailing 6-month period | 31.57% | 0.00% | +31.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 43.09% | 0.00% | +43.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 46.04% | 0.00% | +46.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.34% | 0.00% | +41.34% |
ARKG vs. GERM - Expense Ratio Comparison
ARKG has a 0.75% expense ratio, which is higher than GERM's 0.68% expense ratio.
Dividends
ARKG vs. GERM - Dividend Comparison
Neither ARKG nor GERM has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
ARKG has higher volatility (16.36%) compared to GERM (0.00%). In terms of maximum drawdown, ARKG dropped -83.59% vs GERM's 0.00%.
On 1-year performance, ARKG leads with 59.88% vs 0.00% for GERM. On fees, GERM is cheaper at 0.68% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, ARKG has performed better with a 59.88% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
GERM is cheaper with a 0.68% expense ratio, compared with 0.75% for ARKG.
ARKG and GERM have nearly identical dividend yields, around 0.00%.
They also come from different issuers: ARK and Amplify. Their fees differ too: 0.75% for ARKG and 0.68% for GERM.
Find the right allocation for ARKG and GERM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer